From: Coronavirus disease 2019 outcomes in heart transplant recipients: a single-center case series
Demographics | No. |
---|---|
Total, no. | 13 |
Age, mean (years) | 44.3 |
Male | 9 |
Time, post-transplant, mean (years) | 6.4 |
Hypertension | 3 |
Diabetes mellitus | 3 |
Chronic kidney diseasea | 2 |
Maintenance immunosuppression | |
Total, no. | 13 |
Tacrolimus | 10 |
Cyclosporine | 3 |
Mycophenolate mofetil | 6 |
Mycophenolate sodium | 7 |
Methylprednisolone | 5 |
No. of immunosuppressive medications | |
3 | 13 |
Symptoms | |
Total, no. | 11 |
Asymptomatic | 2 |
Fever | 6 |
Myalgia or malaise | 5 |
Shortness of breath or cough | 7 |
Gastrointestinal symptoms | 3 |
Treatment | |
Total inpatients and outpatients, no. | 13 |
Remdesivir | 9 |
Tocilizumab | 1 |
Interferon beta | 1 |
Intravenous immunoglobulin | 2 |
Dexamethasone | 7 |
Reduction in immunosuppression medications | 8 |
Mycophenolate mofetil held | 9 |
Supplemental oxygen | 6 |
Outcome | |
Total, no. | 13 |
Overall survival | 12 |
Overall mortality | 1 |
Hospitalized | 10 |
In-hospital mortality | 1 |
ICU admission | 2 |
Discharged | 12 |
Managed as outpatient | 3 |
Clinically overt rejection | 0 |